158 related articles for article (PubMed ID: 27107025)
1. Sublingual immunotherapy for allergic rhinitis: subjective versus objective tools to evaluate its success.
Sakurai D; Yonekura S; Iinuma T; Sakurai T; Morimoto Y; Mita Y; Arai T; Suzuki S; Okuma Y; Kaneko S; Okamoto Y
Rhinology; 2016 Sep; 54(3):221-30. PubMed ID: 27107025
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
[TBL] [Abstract][Full Text] [Related]
4. An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis.
Yonekura S; Okamoto Y; Sakurai D; Okubo K; Gotoh M; Kaneko S; Konno A
Allergol Int; 2018 Apr; 67(2):201-208. PubMed ID: 28760534
[TBL] [Abstract][Full Text] [Related]
5. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
[TBL] [Abstract][Full Text] [Related]
6. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
[TBL] [Abstract][Full Text] [Related]
7. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
8. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
[TBL] [Abstract][Full Text] [Related]
11. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
Yonekura S; Gotoh M; Kaneko S; Maekawa Y; Okubo K; Okamoto Y
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190
[TBL] [Abstract][Full Text] [Related]
12. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
Sakashita M; Yamada T; Imoto Y; Hirota T; Tamari M; Ito Y; Kubo S; Osawa Y; Takahashi N; Fujieda S
Cytokine; 2015 Sep; 75(1):181-5. PubMed ID: 25934649
[TBL] [Abstract][Full Text] [Related]
13. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N
Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
[TBL] [Abstract][Full Text] [Related]
15. The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis.
Jerzynska J; Stelmach W; Rychlik B; Lechańska J; Podlecka D; Stelmach I
Allergy Asthma Proc; 2016; 37(2):105-14. PubMed ID: 26932169
[TBL] [Abstract][Full Text] [Related]
16. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
18. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
[TBL] [Abstract][Full Text] [Related]
19. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
Baron-Bodo V; Horiot S; Lautrette A; Chabre H; Drucbert AS; Danzé PM; Sénéchal H; Peltre G; Galvain S; Zeldin RK; Horak F; Moingeon P
Clin Exp Allergy; 2013 Dec; 43(12):1362-73. PubMed ID: 24261946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]